HIV Glasgow 2026: Must-Know EMJ Conference Updates
Hepatitis C coinfection was the strongest independent risk factor for serious liver outcomes in a Swiss cohort of people living with HIV, according to an analysis presented at HIV Glasgow 2026 and reported by the European Medical Journal. The finding identifies hepatitis C as a leading driver of liver risk in this population, even after researchers accounted for other potential contributors.
The analysis compared liver complications among people living with HIV, including those with isolated hepatitis B core antibodies. In the initial comparison, people with isolated hepatitis B core antibodies experienced more liver complications. However, the association weakened after researchers accounted for other risk factors, suggesting that other characteristics partly explained the excess risk seen in that group.
Because hepatitis C coinfection remained the strongest independent risk factor after adjustment, the results place it at the center of liver-risk assessment for people living with HIV in the cohort. The findings were presented at HIV Glasgow 2026.
Original Source: https://www.eatg.org/hiv-news/hiv-glasgow-2026-european-medical-journal-hepatitis-c-coinfection-linked-to-liver-risk-in-hiv/
Category:
Tags:
Publish Date: 2026-11-15 04:33:00